亚型
医学
化疗
放射治疗
肿瘤科
内科学
还原(数学)
癌症
临床试验
疾病
Wnt信号通路
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-07-01
卷期号:54 (4): 774-780
标识
DOI:10.11477/mf.030126030540040774
摘要
amplification, frequently metastasize and have poor outcomes, whereas Group 4 tumors show a more prolonged clinical course. Standard treatment involves maximal safe resection, craniospinal irradiation (CSI), and chemotherapy. However, to mitigate severe late complications, molecular subtyping now enables precision and risk-adapted therapies. This includes exploring CSI dose reduction for the favorable WNT subgroup and utilizing novel molecular biomarkers for Groups 3 and 4. For infants, treatment primarily relies on chemotherapy to avoid CSI. Furthermore, recurrence patterns strongly correlate with these molecular subtypes. Re-biopsy and molecular re-evaluation are crucial upon relapse to distinguish genuine recurrences from radiation-induced secondary tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI